microphotonX utilizes a photonic single-cell platform that combines Raman Spectroscopy and Optical Tweezers to provide antibiotic susceptibility testing results in 30 to 60 minutes. This technology addresses the urgent need for rapid identification and treatment of multidrug-resistant bacterial infections, significantly reducing the time required for actionable clinical decisions.
Funding
$625.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current antibiotic susceptibility testing (AST) methods can take days to produce actionable results, delaying appropriate treatment and contributing to the spread of multidrug-resistant bacteria. The slow turnaround time hinders effective clinical decision-making, especially in cases of severe infection where rapid intervention is critical.
Solution
microphotonX offers a photonic single-cell analysis platform that delivers antibiotic susceptibility testing (AST) results in 30-60 minutes. The system combines Raman Spectroscopy and Optical Tweezers to analyze individual bacterial cells and detect susceptibility even before cell growth is affected. By identifying cellular reprogramming through chemical analysis, the platform provides physicians with rapid, actionable information for optimal treatment selection. The technology enables detection of polymicrobial infections and simultaneous bacterial identification directly from primary samples.
Target Audience
The primary target audience includes physicians and clinical researchers focused on infectious diseases, particularly those needing rapid and accurate AST results to combat multidrug-resistant bacteria.
Features
- Photonic single-cell platform combining Raman Spectroscopy and Optical Tweezers
- Rapid AST results in 30-60 minutes
- Detects susceptibility before cell growth is affected by identifying cellular reprogramming
- Enables detection of polymicrobial infections
- Simultaneous bacterial identification
- Analysis directly from primary samples
- Biospex Analyser 3.0 instrument with automated workflow
- AI-aided analysis platform